The median level in the colorectal cancer patients increased from 98.5 ng/ml in stage I to 137.3 ng/ml in stage IV, with a significantly higher median TIMP-1 level found in stage IV patients compared to stage I–III. This evidence concerns the gene TIMP1 and colorectal cancer.